help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0664
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, W.
Right arrow Articles by Cardozo, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, W.
Right arrow Articles by Cardozo, C. P.
Endocrinology Vol. 149, No. 11 5449-5460
Copyright © 2008 by The Endocrine Society

Expression of the Muscle Atrophy Factor Muscle Atrophy F-Box Is Suppressed by Testosterone

Weidong Zhao, Jiangping Pan, Xiaolei Wang, Yong Wu, William A. Bauman and Christopher P. Cardozo

Center of Excellence for the Medical Consequences of SCI (W.Z., J.P., X.W., Y.W., W.A.B., C.P.C.), James J. Peters Veterans Affairs Medical Center, Bronx, New York 10468; and Department of Medicine (W.A.B., C.P.C.), Mount Sinai School of Medicine, New York, New York 10029

Address all correspondence and requests for reprints to: Dr. Christopher Cardozo, James J. Peters Veterans Affairs Medical Center, Room 1E-02, Bronx, New York 10468. E-mail: chris.cardozo{at}mssm.edu.

The ubiquitin ligase muscle atrophy F-box (MAFbx; also called atrogin-1) is thought to play important roles in muscle loss. Conversely, testosterone reduces atrophy from glucocorticoids or denervation associated with repression of MAFbx. To characterize mechanisms of such repression, the effects of testosterone on MAFbx expression in C2C12 cells were tested. Testosterone reduced MAFbx mRNA levels as well as expression of a reporter gene under the control of 3.1 kb of the human MAFbx promoter. Repression required the androgen receptor (AR) as well as sequences within the first 208 bases upstream of the first codon of the MAFbx gene. This sequence is downstream of known forkhead transcription factor binding sites and testosterone did not alter Forkhead box O 3A phosphorylation. The AR associated with sequences conferring repression in a manner that was stimulated by testosterone and was independent of DNA binding. In gel shift studies, octamer binding transcription factor (Oct)-1 bound two predicted Oct-1 sites within these sequences. Deletion of Oct-1 sites from reporter genes prevented repression by testosterone. Gene knockdown of Oct-1 blocked repression of MAFbx reporter gene activity by testosterone and binding of AR to sequences conferring repression. In conclusion, testosterone represses MAFbx expression via interactions of the AR with Oct-1 that are associated with sequences within the 5' untranslated region of the MAFbx promotor located just upstream of the first codon. This action of testosterone may contribute to beneficial actions of testosterone on muscle.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. Jiao, A. M. Pruznak, D. Huber, T. C. Vary, and C. H. Lang
Castration differentially alters basal and leucine-stimulated tissue protein synthesis in skeletal muscle and adipose tissue
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1222 - E1232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society